These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 4152191)

  • 1. Liver structure and function in cholelithiasis: effect of chenodeoxycholic acid.
    Bell GD; Mok HY; Thwe M; Murphy GM; Henry K; Dowling RH
    Gut; 1974 Mar; 15(3):165-72. PubMed ID: 4152191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of different doses of chenodeoxycholic acid on bile-lipid composition and on frequency of side-effects in patients with gallstones.
    Mok HY; Bell GD; Dowling RH
    Lancet; 1974 Aug; 2(7875):253-7. PubMed ID: 4135688
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies of liver function and structure in patients with gallstones before and during treatment with chenodeoxycholic acid.
    Fromm H; Holz-Slomczyk M; Zobl H; Schmidt E; Schmidt FW
    Acta Hepatogastroenterol (Stuttg); 1975 Dec; 22(6):359-69. PubMed ID: 1211062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gallstone dissolution in man using chenodeoxycholic acid.
    Bell GD; Whitney B; Dowling RH
    Lancet; 1972 Dec; 2(7789):1213-6. PubMed ID: 4117706
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter: Chenodeoxycholic acid and the liver.
    Bainton D; Rhodes J; Davies GT; Evans KT
    Lancet; 1974 Mar; 1(7857):562. PubMed ID: 4132000
    [No Abstract]   [Full Text] [Related]  

  • 6. Ursodeoxycholic acid versus chenodeoxycholic acid. Comparison of their effects on bile acid and bile lipid composition in patients with cholesterol gallstones.
    Stiehl A; Czygan P; Kommerell B; Weis HJ; Holtermüller KH
    Gastroenterology; 1978 Dec; 75(6):1016-20. PubMed ID: 30674
    [No Abstract]   [Full Text] [Related]  

  • 7. Proceedings: The effects of different doses of chenodeoxycholic acid and of withdrawing treatment on bile lipid composition and liver function in patients with gallstones.
    Mok HY; Bell GD; Dowling RH
    Gut; 1974 Apr; 15(4):340. PubMed ID: 4834569
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of gallstone-dissolution therapy on human liver structure.
    Bateson MC; Hopwood D; Bouchier IA
    Am J Dig Dis; 1977 Apr; 22(4):293-9. PubMed ID: 16480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Light and electron microscopy of human liver before and during chenodeoxycholic acid therapy.
    Hartmann W; Paulini K; Goebell H
    Hepatogastroenterology; 1980 Apr; 27(2):91-8. PubMed ID: 7216131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of hyperbilirubinemia during treatment with chenodeoxycholic acid.
    Nakashima T; Sano A; Seto Y; Nakajima T; Okuno T; Takino T
    Jpn J Med; 1987 Aug; 26(3):404-8. PubMed ID: 3694926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile acid-induced liver toxicity: relation to the hydrophobic-hydrophilic balance of bile acids.
    Attili AF; Angelico M; Cantafora A; Alvaro D; Capocaccia L
    Med Hypotheses; 1986 Jan; 19(1):57-69. PubMed ID: 2871479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective comparison of 'Cheno' and 'Urso' in the medical treatment of gallstones.
    Meredith TJ; Williams GV; Maton PN; Murphy GM; Saxton HM; Dowling RH
    Gut; 1982 May; 23(5):382-9. PubMed ID: 7076015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of response to chenodeoxycholic acid in obese and non-obese patients. Role of cholesterol synthesis and possible response to ursodeoxycholic acid.
    Maton PN; Murphy GM; Dowling RH
    Gut; 1980 Dec; 21(12):1082-6. PubMed ID: 7461467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum enzyme levels in alcoholism and drug dependency.
    Patel S; O'Gorman P
    J Clin Pathol; 1975 May; 28(5):414-7. PubMed ID: 239023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Speed of change in biliary lipids and bile acids with chenodeoxycholic acid--is intermittent therapy feasible?
    Iser JH; Murphy GM; Dowling RH
    Gut; 1977 Jan; 18(1):7-15. PubMed ID: 838406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to chenodeoxycholic acid (CDCA) treatment in obese patients with gall stones.
    Iser JH; Maton PN; Murphy GM; Dowling RH
    Br Med J; 1978 Jun; 1(6126):1509-12. PubMed ID: 656777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chenodeoxycholic acid: a review of its pharmacological properties and therapeutic use.
    Iser JH; Sali A
    Drugs; 1981 Feb; 21(2):90-119. PubMed ID: 7009140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled trial of chenodeoxycholic therapy for radiolucent gallstones. A multicenter study.
    Gerolami A; Sarles H; Brette R; Paraf A; Rautureau J; Debray C; Bermann C; Etienne JP; Chaput JC; Petite JP
    Digestion; 1977; 16(4):299-307. PubMed ID: 355026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chenodeoxycholic acid on liver structure and function in man: a stereological and biochemical study.
    Koch MM; Giampieri MP; Lorenzini I; Jezequel AM; Orlandi F
    Digestion; 1980; 20(1):8-21. PubMed ID: 6766420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chenodeoxycholic acid treatment of gallstones: a survey of 25 patients (author's transl)].
    Métreau JM; Saint-Marc Girardin MF; Dhumeaux D; Berthelot P
    Nouv Presse Med; 1978 Nov; 7(38):3437-40. PubMed ID: 740522
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.